This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University System of Maryland. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 3,696 
3 out of 2,027 
Years Active: 2019-2025
Title: Julie Hixon: Innovator in Cancer Treatment
Introduction
Julie Hixon is a prominent inventor based in Hagerstown, MD (US), known for her significant contributions to the field of cancer treatment. With a total of 4 patents, she has made remarkable strides in developing innovative therapies aimed at combating acute lymphoblastic leukemia and other cancers.
Latest Patents
Hixon's latest patents include groundbreaking work on IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia. This patent discloses antibodies and antigen binding fragments that specifically bind to IL-7Rα. It also provides nucleic acids encoding these antibodies and antigen binding fragments, along with vectors that include the nucleic acid molecules. Furthermore, methods for detecting cancer or cells that express IL-7Rα using these antibodies and fragments are disclosed, highlighting their potential use in preventing and treating cancers that express IL-7Rα.
Another notable patent involves peptide hydrogels and their applications. This disclosure presents novel anionic amphiphilic β-hairpin peptides that self-assemble under specific conditions to form a reversible gel-sol hydrogel. This innovative hydrogel can be utilized to deliver protein therapeutics and cells by injection to targeted locations within a subject.
Career Highlights
Throughout her career, Hixon has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University System of Maryland. Her work has significantly impacted the development of therapeutic strategies in oncology.
Collaborations
Hixon has collaborated with notable colleagues such as Scott Walsh and Scott Durum, contributing to her innovative research and development efforts.
Conclusion
Julie Hixon's contributions to cancer treatment through her patents and collaborations underscore her role as a leading inventor in the field. Her innovative approaches continue to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile